Kinnate Biopharma Inc.
KNTE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$113 | -$116 | -$90 | -$36 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | -$27 | $0 | $0 | $0 |
| Stock-Based Comp. | $20 | $20 | $15 | $2 |
| Change in WC | -$4 | $6 | $2 | $3 |
| Other Non-Cash | $22 | $1 | $2 | $0 |
| Operating Cash Flow | -$100 | -$89 | -$71 | -$30 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$3 | -$1 | -$0 |
| Net Acquisitions | -$9 | $0 | $35 | $0 |
| Inv. Purchases | -$155 | -$177 | -$247 | -$31 |
| Inv. Sales/Matur. | $265 | $172 | $67 | $0 |
| Other Inv. Act. | $0 | -$0 | -$35 | -$0 |
| Investing Cash Flow | $101 | -$7 | -$181 | -$32 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $1 | $0 | $0 | $253 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$8 | $1 | $36 | $351 |
| Financing Cash Flow | $1 | $0 | $0 | $351 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2 | -$95 | -$215 | $289 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $55 | $150 | $365 | $76 |
| End Cash | $57 | $55 | $150 | $365 |
| Free Cash Flow | -$100 | -$92 | -$72 | -$30 |